Literature DB >> 18715926

Kinetic analysis by real-time PCR of hepatitis C virus (HCV)-specific T cells in peripheral blood and liver after challenge with HCV.

Ramesh K Ramalingam1, Dirk Meyer-Olson, Naglaa H Shoukry, David G Bowen, Christopher M Walker, Spyros A Kalams.   

Abstract

Intrahepatic virus-specific CD8(+) T cells are thought to be important for the control of hepatitis C virus (HCV) infection, yet the precise kinetics for the expansion of epitope-specific T cells over the course of infection are difficult to determine with currently available methods. We used a real-time PCR assay to measure the frequency of clonotypic HCV-specific CD8(+) T cells in peripheral blood and snap-frozen liver biopsy specimens of two chimpanzees (Pan troglodytes) with previously resolved HCV infection who were rechallenged with HCV. In response to rechallenge, the magnitude of each clonotypic response was 10-fold higher in the liver than in the blood, and the peak clonotype frequency was concurrent with the peak viral load. The higher frequency of HCV-specific clonotypes in the liver than in peripheral blood was maintained for at least 3 months after the clearance of viremia. After antibody-mediated CD8(+) T-cell depletion and another viral challenge, the rebound of these clonotypes was seen prior to an appreciable reconstitution of CD8(+) T-cell values and, again, at higher frequencies in the liver than in peripheral blood. These data demonstrate the importance of intrahepatic virus-specific CD8(+) T cells for the clearance of infection and the rapid kinetics of expansion after virus challenge.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18715926      PMCID: PMC2573177          DOI: 10.1128/JVI.00588-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape.

Authors:  Daniel C Douek; Michael R Betts; Jason M Brenchley; Brenna J Hill; David R Ambrozak; Ka-Leung Ngai; Nitin J Karandikar; Joseph P Casazza; Richard A Koup
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

2.  Tracking T cell clonotypes in complex T lymphocyte populations by real-time quantitative PCR using fluorogenic complementarity-determining region-3-specific probes.

Authors:  Alexandra Gallard; Gilles Foucras; Christiane Coureau; Jean-Charles Guéry
Journal:  J Immunol Methods       Date:  2002-12-15       Impact factor: 2.303

3.  In Vivo Persistence of Codominant Human CD8+ T Cell Clonotypes Is Not Limited by Replicative Senescence or Functional Alteration.

Authors:  Laurent Derré; Marc Bruyninx; Petra Baumgaertner; Estelle Devevre; Patricia Corthesy; Cédric Touvrey; Yolanda D Mahnke; Hanspeter Pircher; Verena Voelter; Pedro Romero; Daniel E Speiser; Nathalie Rufer
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

4.  Persistence of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte clones in a subject with rapid disease progression.

Authors:  S A Islam; C M Hay; K E Hartman; S He; A K Shea; A K Trocha; M J Dynan; N Reshamwala; S P Buchbinder; N O Basgoz; S A Kalams
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.

Authors:  Robert Thimme; Stefan Wieland; Carola Steiger; John Ghrayeb; Keith A Reimann; Robert H Purcell; Francis V Chisari
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders.

Authors:  Paolo A Muraro; Klaus-Peter Wandinger; Bibiana Bielekova; Bruno Gran; Adriana Marques; Ursula Utz; Henry F McFarland; Steve Jacobson; Roland Martin
Journal:  Brain       Date:  2003-01       Impact factor: 13.501

7.  Combination of MHC-peptide multimer-based T cell sorting with the Immunoscope permits sensitive ex vivo quantitation and follow-up of human CD8+ T cell immune responses.

Authors:  Annick Lim; Véronique Baron; Laurent Ferradini; Marc Bonneville; Philippe Kourilsky; Christophe Pannetier
Journal:  J Immunol Methods       Date:  2002-03-01       Impact factor: 2.303

8.  Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee.

Authors:  David J Woollard; Arash Grakoui; Naglaa H Shoukry; Krishna K Murthy; Katherine J Campbell; Christopher M Walker
Journal:  Hepatology       Date:  2003-11       Impact factor: 17.425

9.  Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.

Authors:  Heiner Wedemeyer; Xiao-Song He; Michelina Nascimbeni; Anthony R Davis; Harry B Greenberg; Jay H Hoofnagle; T Jake Liang; Harvey Alter; Barbara Rehermann
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

10.  Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection.

Authors:  Naglaa H Shoukry; Arash Grakoui; Michael Houghton; David Y Chien; John Ghrayeb; Keith A Reimann; Christopher M Walker
Journal:  J Exp Med       Date:  2003-06-16       Impact factor: 14.307

View more
  5 in total

1.  Antigen-Specificity of T Cell Infiltrates in Biopsies With T Cell-Mediated Rejection and BK Polyomavirus Viremia: Analysis by Next Generation Sequencing.

Authors:  G Zeng; Y Huang; Y Huang; Z Lyu; D Lesniak; P Randhawa
Journal:  Am J Transplant       Date:  2016-07-15       Impact factor: 8.086

Review 2.  Immunity and hepatitis C: a review.

Authors:  Rebecca R Terilli; Andrea L Cox
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

3.  Selective expansion of high functional avidity memory CD8 T cell clonotypes during hepatitis C virus reinfection and clearance.

Authors:  Mohamed S Abdel-Hakeem; Maude Boisvert; Julie Bruneau; Hugo Soudeyns; Naglaa H Shoukry
Journal:  PLoS Pathog       Date:  2017-02-01       Impact factor: 6.823

4.  Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery.

Authors:  D Christiansen; L Earnest-Silveira; B Grubor-Bauk; D K Wijesundara; I Boo; P A Ramsland; E Vincan; H E Drummer; E J Gowans; J Torresi
Journal:  Sci Rep       Date:  2019-06-25       Impact factor: 4.379

5.  Strong vaccine-induced CD8 T-cell responses have cytolytic function in a chimpanzee clearing HCV infection.

Authors:  Babs E Verstrepen; Ernst J Verschoor; Zahra C Fagrouch; Petra Mooij; Natasja G de Groot; Ronald E Bontrop; Willy M Bogers; Jonathan L Heeney; Gerrit Koopman
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.